{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:12Z","timestamp":1794047412955,"version":"4.8.0"},"reference-count":168,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"6","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-immune-mediated mechanisms. Non-immune-mediated thrombocytopenia is due to direct toxicity of drug molecules to platelets or megakaryocytes. Immune-mediated thrombocytopenia, on the other hand, involves the formation of antibodies that react to platelet-specific glycoprotein complexes, as in classic drug-induced immune thrombocytopenia (DITP), or to platelet factor 4, as in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT). Clinical signs include a rapid drop in platelet count, bleeding or thrombosis. Since the patient's condition can deteriorate rapidly, prompt diagnosis and management are critical. However, the necessary diagnostic tests are only available in specialized laboratories. Therefore, the most demanding step in treatment is to identify the agent responsible for thrombocytopenia, which often proves difficult because many patients are taking multiple medications and have comorbidities that can themselves also cause thrombocytopenia. While DITP is commonly associated with an increased risk of bleeding, HIT and VITT have a high mortality rate due to the high incidence of thromboembolic complications. A structured approach to drug-associated thrombocytopenia\/thrombosis can lead to successful treatment and a lower mortality rate. In addition to describing the treatment of DITP, HIT, VITT, and vaccine-associated immune thrombocytopenia, this review also provides the pathophysiological and clinical information necessary for correct patient management.<\/jats:p>","DOI":"10.3324\/haematol.2021.279484","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T15:09:17Z","timestamp":1654096157000},"page":"1264-1277","source":"Crossref","is-referenced-by-count":71,"title":["Treatment of drug-induced immune thrombocytopenias"],"prefix":"10.3324","volume":"107","author":[{"given":"Irene","family":"Marini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunalp","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinan","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamam","family":"Bakchoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"36195","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-46202-0.00007-8"},{"key":"36196","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640578"},{"key":"36197","unstructured":"Kuter D. Clinical applications of thrombopoietic growth factors.Publisher Full Text|"},{"key":"36198","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2016.10.013"},{"key":"36199","unstructured":"National Institutes of Health NCI. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017."},{"key":"36200","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6"},{"key":"36201","unstructured":"Slichter SJ. Optimizing platelet transfusions in chronically thrombocytopenic patients. Semin Hematol. 1998; 35(3):269-278."},{"key":"36202","unstructured":"Slichter SJ, LeBlanc R, Jones MK. Quantitative analysis of bleeding risk in cancer patients (PTS) prophylactically transfused at platelet (PLT) counts (CTS) of, 5,000, 10,000, or 20,000. Blood. 1999; 94(3):376a."},{"key":"36203","doi-asserted-by":"publisher","DOI":"10.1016\/S0308-2261(21)00047-3"},{"key":"36204","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V66.5.1105.1105"},{"key":"36205","unstructured":"Chantarangkul V, Clerici M, Bressi C, Giesen PL, Tripodi A.. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica. 2003; 88(5):547-554."},{"key":"36206","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04771.x"},{"key":"36207","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904084"},{"key":"36208","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.4.1137"},{"key":"36209","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012035.pub2"},{"key":"36210","unstructured":"Hassan BA, Yusoff ZB, Hassali MA, Bin Othman S. Treatment patterns and outcomes in management of solid cancer patients suffering from thrombocytopenia in Penang hospital. Asian Pac J Cancer Prev. 2011; 12(11):2841-2845."},{"key":"36211","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197207272870401"},{"key":"36212","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.9.1377"},{"key":"36213","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2416-x"},{"key":"36214","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2015.03.001"},{"key":"36215","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04875-1"},{"key":"36216","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2018.02.003"},{"key":"36217","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0399-y"},{"key":"36218","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.12.019"},{"key":"36219","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.12.017"},{"key":"36220","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-131"},{"key":"36221","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.251900"},{"key":"36222","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.660628"},{"key":"36223","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11934"},{"key":"36224","doi-asserted-by":"publisher","DOI":"10.1080\/10428190903026492"},{"key":"36225","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10369"},{"key":"36226","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08707.x"},{"key":"36227","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001617"},{"key":"36228","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1313905110"},{"key":"36229","doi-asserted-by":"publisher","DOI":"10.1038\/nm1760"},{"key":"36230","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17872"},{"key":"36231","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24759"},{"key":"36232","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065066"},{"key":"36233","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.11.1010.34517"},{"key":"36234","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-19.2.72"},{"key":"36235","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2008.00942.x"},{"key":"36236","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276691"},{"key":"36237","unstructured":"Gonzalez CE, Pengetze YM. Post-transfusion purpura. Curr Hematol Rep. 2005; 4(2):154-159."},{"key":"36238","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S189176"},{"key":"36239","unstructured":"Levi M.. Cancer and DIC. Haemostasis. 2001; 31(Suppl 1):47-8."},{"key":"36240","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-79962-9_9"},{"key":"36241","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013321"},{"key":"36242","unstructured":"Kuter DJ, Rosenberg RD. Disorders of hemostasis. 1991;577-598."},{"key":"36243","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20290"},{"key":"36244","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1687893"},{"key":"36245","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21276"},{"key":"36246","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.12.565"},{"key":"36247","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700747"},{"key":"36248","doi-asserted-by":"publisher","DOI":"10.2165\/11594310-000000000-00000"},{"key":"36249","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.11.020"},{"key":"36250","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13595"},{"key":"36251","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191206"},{"key":"36252","unstructured":"Wright JH. A rapid method for the differential staining of blood films and malarial parasites. J Medical Res. 1902; 7(1):138-144."},{"key":"36253","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM190606071542301"},{"key":"36254","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12758"},{"key":"36255","doi-asserted-by":"publisher","DOI":"10.1038\/nature21706"},{"key":"36256","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-259663"},{"key":"36257","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110750"},{"key":"36258","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-307-3_5"},{"key":"36259","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-394858"},{"key":"36260","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.11.4446.423k19_4446_4452"},{"key":"36261","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.1981.tb00513.x"},{"key":"36262","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.5.1036.bloodjournal6451036"},{"key":"36263","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318210e685"},{"key":"36264","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2093"},{"key":"36265","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)80186-6"},{"key":"36266","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1173"},{"key":"36267","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402081"},{"key":"36268","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0939"},{"key":"36269","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.2000.00305.x"},{"key":"36270","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.6.2260.h81802002260_2260_2262"},{"key":"36271","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712253372602"},{"key":"36272","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28253"},{"key":"36273","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21958"},{"key":"36274","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009733.pub2"},{"key":"36275","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-138920"},{"key":"36276","unstructured":"Tepler I, Elias L, Smith JW. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood. 1996; 87(9):3607-3614."},{"key":"36277","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7610"},{"key":"36278","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.2.651"},{"key":"36279","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(98)90057-9"},{"key":"36280","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.3.803.803"},{"key":"36281","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.3.795.003k25_795_801"},{"key":"36282","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.9.2720"},{"key":"36283","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110352"},{"key":"36284","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01359.x"},{"key":"36285","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0652-8"},{"key":"36286","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530140711"},{"key":"36287","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4068.bloodjournal87104068"},{"key":"36288","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2028.x"},{"key":"36289","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.6.3132"},{"key":"36290","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.1.139"},{"key":"36291","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1920.x"},{"key":"36292","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2234"},{"key":"36293","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-405"},{"key":"36294","unstructured":"Columbyova L, Loda M, Scadden DT. Thrombopoietin receptor expression in human cancer cell lines and primary tissues. Cancer Res. 1995; 55(16):3509-3512."},{"key":"36295","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12781"},{"key":"36296","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.2.511.bloodjournal882511"},{"key":"36297","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.10.3457"},{"key":"36298","unstructured":"Li J, Xia Y, Bertino A, Coburn J, Kuter DJ. Characterization of an anti-thrombopoietin antibody that developed in a cancer patient following the injection of PEG-rHuMGDF. Blood. 1999; 94:51a."},{"key":"36299","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3241"},{"key":"36300","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.7.2599"},{"key":"36301","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761262"},{"key":"36302","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.05975.x"},{"key":"36303","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1841748"},{"key":"36304","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V104.11.2909.2909"},{"key":"36305","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2008-0366"},{"key":"36306","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2004.09.006"},{"key":"36307","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2010.02.005"},{"key":"36308","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-013-1382-0"},{"key":"36309","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-2296-9.00008-7"},{"key":"36310","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12260"},{"key":"36311","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002625"},{"key":"36312","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-313908"},{"key":"36313","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01575-1"},{"key":"36314","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073255"},{"key":"36315","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-534743"},{"key":"36316","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200931"},{"key":"36317","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702063360603"},{"key":"36318","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.15.2852"},{"key":"36319","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm341"},{"key":"36320","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-5-200003070-00005"},{"key":"36321","unstructured":"Bai CM, Xu GX, Zhao YQ, Han SM, Shan YD. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004; 26(4):437-441."},{"key":"36322","unstructured":"Bai CM, Zou XY, Zhao YQ, Han SM, Shan YD. Thrombopoietin Clinical Trial Cooperation Group. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia]. Zhonghua Yi Xue Za Zhi. 2004; 84(5):397-400."},{"key":"36323","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1459605"},{"key":"36324","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/141134"},{"key":"36325","unstructured":"Abudurousuli R, Luo T, Liu R. Research on the recombinant human thrombopoietin in the treatment of thrombocytopenia caused by tumor chemotherapy: a meta-analysis. In J Intell Syst. 2121; 3:184-192."},{"key":"36326","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-2074-2"},{"key":"36327","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01931"},{"key":"36328","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.180166"},{"key":"36329","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.510051"},{"key":"36330","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.326"},{"key":"36331","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2319-9"},{"key":"36332","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.701539"},{"key":"36333","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.12.4336"},{"key":"36334","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030288"},{"key":"36335","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1134::AID-CNCR17>3.0.CO;2-9"},{"key":"36336","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.01.011"},{"key":"36337","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.093872"},{"key":"36338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.3332"},{"key":"36339","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-020-01101-4"},{"key":"36340","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-012-1822-1"},{"key":"36341","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2008.40.1.22"},{"key":"36342","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.9007"},{"key":"36343","doi-asserted-by":"publisher","DOI":"10.1159\/000320640"},{"key":"36344","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.08.015"},{"key":"36345","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330"},{"key":"36346","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2012.13.5.1837"},{"key":"36347","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0375"},{"key":"36348","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.9114"},{"key":"36349","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60313-X"},{"key":"36350","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-011-0360-x"},{"key":"36351","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-008-9217-1"},{"key":"36352","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.11.2976"},{"key":"36353","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.21.9220"},{"key":"36354","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2020.10.004"},{"key":"36355","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209124"},{"key":"36356","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.2071"},{"key":"36357","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.5902"},{"key":"36358","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70178-0"},{"key":"36359","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505270"},{"key":"36360","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.658"},{"key":"36361","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2013.14.11.6585"},{"key":"36362","unstructured":"Kuter DJ. Managing thrombocytopenia associated with cancer chemotherapy. Oncology (Williston Park). 2015; 29(4):282-294."}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.279484\/74474","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.279484\/74520","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10654\/74474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:01:50Z","timestamp":1794045710000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2021.279484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":168,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2021.279484","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,19]]}}}